Boehringer’s lung cancer drug gets EMA nod
September 29, 2014Sales and Marketing Boehringer, IPF, docetaxel, ingelheim, lung cancer, nintedanib
The EMA has issued a positive opinion for the approval of Boehringer Ingelheim’s nintedanib in combination with docetaxel for the …
NHS stem cell research link up
September 29, 2014Research and Development, Sales and Marketing NHS, precious cells group, precious cells miracle, stem cell
Precious Cells Miracle, the charitable arm of stem cell firm Precious Cells Group, has partnered with the Croydon Health Services …
Sovaldi combo sees CHMP green light
September 29, 2014Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi
The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …
Roche’s Perjeta sees ‘impressive’ survival rates
September 29, 2014Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid
Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …
Daiichi Sankyo pays $410m for Ambit Biosciences
September 29, 2014Sales and Marketing AML, Daiichi Sankyo, ambit biosciences, quizartinib
Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. …
Adaptimmune board changes amid funding boost
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Ali Behbahani, Elliott Sigal, Peter Thompson, david mott
Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …
Is clinical research management evidence-based?
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Six Sigma, clinical trials, evidence, neuro-linguistic
Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …
Novartis: digital pharma company of the year
September 26, 2014Medical Communications, Sales and Marketing London, McCann Manchester and Red Door Communications, Novartis, pm society
Novartis pipped Bayer and its big pharma rivals Boehringer, Genentech, GSK and Sanofi to the post in receiving the first …
Virgo Health appoints US office head
September 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, nancy caravetta
UK-based healthcare comms agency Virgo Health has launched a PR office in New York and appointed Nancy Caravetta to head …
Shire accused of dishonest marketing in US
September 25, 2014Medical Communications, Sales and Marketing Adderall XR, Department of Justice, DoJ, Shire, US, amphetamine, dextroamphetamine
Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …
PAN hires two account handlers
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Margaux Chung, Pan, Rosemary Behan
Creative agency PAN has appointed two new account handlers in Rosemary Behan (pictured) who joins as account director, and Margaux …
New chairman to take seat at GSK
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, gent, philip hampton
The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …
MedImmune and CRUK team up on cancer
September 25, 2014Sales and Marketing AstraZeneca, CRT, CRUK, Cambridge, Cancer, MedImmune
AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …
Avillion hires chief business officer
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion, Jarrod Longcor, melinta, rib-x
London-based drug development firm Avillion has confirmed the appointment of Jarrod Longcor as its chief business officer. Longcor joins as …
FDA accepts new schizophrenia drug filing
September 24, 2014Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia
The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …
Boehringer to slash 600 jobs in native Germany
September 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff
Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …
Labour makes NHS central to 2015 election pledge
September 24, 2014Sales and Marketing 2015 election, Conservative, GPs, Labour, NHS, manifesto, nurses
The Labour Opposition party has set out its plans to ‘save and transform’ the NHS and has made this the key …
Novella Clinical hires European director
September 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical, deepak dhami, novella
Contract research organisation Novella Clinical has appointed Dr Deepak Dhami as the director of its clinical monitoring unit for Europe. …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
NHS launches transparency website
September 23, 2014Medical Communications, Sales and Marketing NHS, NHS England, mynhs, transparency, website
NHS England has launched a new ‘comparison website tool’ that allows health and social care organisations to see how their …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
